Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting
Nkemakonam C. Okoye, Adam P. Barker, Kenneth Curtis, Richard R. Orlandi, Emily A. Snavely, Cameron Wright, Kimberly E. Hanson, L. Pearson
Abstract
We compared the performance of the Abbott BinaxNOW COVID-19 antigen card to that of a standard reverse transcription-PCR (RT-PCR) assay (Thermo Fisher TaqPath COVID-19 Combo kit) for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2,645 asymptomatic students presenting for screening at the University of Utah. SARS-CoV-2 RNA was detected in 1.7% of the study participants by RT-PCR.
Topics & Concepts
AsymptomaticCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medicine2019-20 coronavirus outbreakVirologyAntigenBetacoronavirusImmunologyInternal medicineInfectious disease (medical specialty)DiseaseOutbreakSARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 ResearchBiosensors and Analytical Detection